NA, not applicable Discussion This study showed that increases in the total quantity of drugs prescribed for outpatients were associated with the prescribing of more PIMs and more overlapping DSA. quantity of prescription drugs improved. The odds percentage SR9011 (OR) of overlapping DSAs was significantly higher in individuals using 5 or more medicines. In addition, there have been significantly more prescriptions of laxatives among individuals with overlapping prescriptions of anticholinergic medicines. The use of almost all PIMs was not an independent risk element for hospitalization; instead, the number of PIMs was an independent risk element for hospitalization [OR 1.18 (95% CI, 1.12C1.26)]. Conclusions The number of PIMs and overlapping DSAs were high in individuals receiving multidrug treatment. To avoid adverse events and hospitalization, it might be SR9011 useful to evaluate prescriptions and consider the number of PIMs and overlapping DSAs. value was .001 Table 2 Prevalence of medicines that should be prescribed with special caution valuestest was used to compare the differences between each group (a,b). Correction with the Bonferroni method was performed, and ideals .017 were considered significant. *value /th th rowspan=”1″ colspan=”1″ hospitalized/Total (%) /th /thead Age0.99 (0.98C0.99).001**Sex?Male1113/5653 (19.7)1.56 (1.40C1.72) .001***?Female787/5588 (14.1)Total number of medicines1.06 (1.03C1.08) .001***Quantity of medical departments1.43 (1.29C1.59) .001***Benzodiazepine derivatives142/770 (18.4)0.90 (0.74C1.10)0.314Non-benzodiazepine hypnotics78/380 (20.5)1.11 (0.85C1.45)0.439Tricyclic antidepressants9/45 (20.0)1.09 (0.51C2.35)0.821Sulpiride2/24 (8.3)0.36 (0.81C1.58)0.173Antiparkinsonian drugs4/35 (11.4)0.64 (0.22C1.84)0.409(anticholinergic drugs)Combined therapy with multiple antithrombotic drugs80/270 (29.7)1.26 (0.94C1.69)0.116(antiplatelet medicines, anticoagulants)Digoxin ( ? 0.125?mg/day time)1/6 (16.7)0.27 (0.30C2.48)0.249Loop diuretics198/596 (33.2)1.73 (1.38C2.16) .001***Alderostone antagonists123/409 (30.1)1.24 (0.95C1.61)0.1081-Receptor blockers20/105 (19.0)0.74 (0.44C1.24)0.25nonselective for receptor subtypesH1 receptor antagonists11/49 (22.4)0.98 (0.49C1.98)0.965(1st generation)H2 receptor antagonists107/647 (16.5)0.80 (0.64C0.99).044*Antiemetic drugs34/126 (27.0)1.45 (0.96C2.19)0.079Sulfonylureas27/173 (15.6)0.71 (0.45C1.12)0.14Biguanides49/291 (16.8)0.82 (0.58C1.17)0.274Thiazolidine derivatives10/89 (11.2)0.53 (0.27C1.08)0.079-Glucosidase inhibitors45/212 (21.2)1.04 (0.72C1.50)0.847SGLT2 inhibitors4/40 (10.0)0.48 (0.17C1.42)0.185Muscarinic receptor antagonists18/139 (12.9)0.58 (0.35C0.96)0.036Oxybutynin (oral)0/3 (0)NANSAIDs197/836 (23.5)1.29 (1.08C1.54).006** Open in a separate window SR9011 ?Modified for age, making love, quantity of medical departments, and use of additional PIMs. The odds percentage (OR) was determined using logistic regression analysis. em p /em ? ?.05 was considered statistically significant. * em p /em ? ?.05; ** em p /em ? ?.01; *** em p /em ? ?.001. NA, not applicable Conversation This study showed that raises in the total quantity of medicines prescribed for outpatients were associated with Furin the prescribing of more PIMs and more overlapping DSA. Earlier reports on prescriptions for the elderly in Japan are limited. As this survey obtained similar results to those of additional countries, improved PIMs due to multidrug use may be a common issue across countries. Presently, little info exists within the status of the prescription issuance of PIMs in the STOPP-J. Consequently, our findings may be useful for long term medical care of the elderly in Japan. Our findings showed that overlapping DSAs improved amazingly in the 5C9-medicines group compared to that in the 1C4-medicines group. We found many instances where laxatives were prescribed for individuals receiving overlapping medicines with anticholinergic effects, suggesting that drug-induced constipation improved owing to the overlapping of medicines with anticholinergic effects. The proportion of overlapping DSAs was markedly higher in the 5C9-medicines group than in SR9011 the 1C4-medicines group without significant difference. Kojima et al. reported that falling and additional drug-related adverse events increase in elderly individuals concurrently using more than 5 or 6 medicines [14, 15], and our results may clarify one of these events. We also found that the number of PIMs was an independent risk element for hospitalization, but the use of PIMs except for loop diuretics and NSAIDs was not. The presence or absence of PIMs was reported to impact hospitalization [16, 17], and SR9011 a high quantity of hospitalizations was indicated in individuals using specific medicines, such as loop diuretics and NSAIDs [18, 19]. It was reported that the use of loop diuretics is definitely more likely.